Long answer keep reading, because the details matter far more than the headline
Therapeutic modulation of the microbiome shows promise: antibiotics targeting dysbiotic bacteria and fecal microbiota transfer (FMT) reduce lesion growth in preclinical models, while probiotics restoring Lactobacillus dominance improve NK cell activity and reproductive outcomes
One of the most promising drug classes in recent years is GLP-1 receptor agonists, including semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).These medications have revolutionized weight loss and diabetes management, with additional potential benefits in reducing risks for conditions like sleep apnea, cardiovascular disease, and even alcohol dependence
However, a slight numerical increase in suicidal ideation was observed among liraglutide recipients, with nine cases (0.3%) in the liraglutide group compared to two cases (0.1%) in the placebo group [71]